sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Broad-spectrum therapeutics against SARS-CoV-2 3CL protease

$681,379

Raymond F. Schinazi · Emory University · R01 · FY2021 · AI

Porous silicon microparticle-based subunit vaccines for SARS-CoV-2

$681,312

Tian Wang · University Of Texas Med Br Galveston · R01 · FY2025 · AI

Developing a dynamic modeling framework for surveillance, prediction, and real-time resource allocation to reduce health disparities during Covid-19 and future pandemics

$681,194

Lior Rennert · Clemson University · R01 · FY2023 · LM

Administrative Supplement to Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device

$680,708

Daniel Kim · Northwestern University At Chicago · R01 · FY2020 · HL

Therapeutic Electrical Stimulation Using Wireless, Resorbable Implants to Accelerate Diaphragm Muscle Reinnervation after Phrenic Neuropathy

$680,366

Colin Franz · Rehabilitation Institute Of Chicago D/B/A Shirley Ryan Abilitylab · R01 · FY2024 · NS

Administrative Core

$680,221

Fred R Hirsch · Icahn School Of Medicine At Mount Sinai · U54 · FY2020 · CA

Determinants of Early Childhood Immune Responses

$679,676

Mary Prahl · University Of California, San Francisco · R01 · FY2025 · HD

Dynamic Interactions of the S-Nitrosoproteome in Type 2 Diabetes/Metabolic Syndrome and Alzheimer's Disease

$679,644

Stuart A Lipton · Scripps Research Institute, The · RF1 · FY2020 · AG

Early Drivers of Humoral Immunity to SARS-CoV-2 Infections

$679,626

Christopher L King · Case Western Reserve University · U01 · FY2022 · CA

Systems modeling to address the social and biological drivers of disparities in infection and mortality from emerging infectious diseases

$679,307

Jonathan L Zelner · University Of Michigan At Ann Arbor · R01 · FY2022 · MD

Improving the Collaborative Health of Minority COVID-19 Survivor & Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities

$679,180

Gayenell Smith Magwood · University Of South Carolina At Columbia · R01 · FY2022 · NR

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

$678,903

Harel Dahari · Loyola University Chicago · R01 · FY2025 · AI

Mitochondrial deubiquitinase USP30 regulates cell metabolism-mediated miRNA biogenesis and microvascular inflammation

$678,803

Yutong Zhao · Ohio State University · R01 · FY2025 · HL

Discovery of SARS-CoV-2 antivirals using a replicon assay

$678,703

Stefan G Sarafianos · Emory University · R01 · FY2024 · AI

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

$678,376

William Gerald Teague · University Of Virginia · R01 · FY2025 · AI

Long-Term Endothelial Effects of COVID-19 in Obesity

$678,331

Jennifer E Ho · Beth Israel Deaconess Medical Center · R01 · FY2025 · HL

Serological Science for COVID-19 SeroNet

$678,192

Leonard Freedman · Leidos Biomedical Research, Inc. · N01 · FY2023 · CA

Functional Role of HIF-PHDs in ARDS

$678,102

Holger K. Eltzschig · University Of Texas Hlth Sci Ctr Houston · R01 · FY2025 · HL

Long-Term Endothelial Effects of COVID-19 in Obesity

$678,030

Jennifer E Ho · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL

Emergence, Progression and Impact of SARS-CoV-2 Variants in West Virginia

$678,030

Sally Lynn Hodder · West Virginia University · U54 · FY2021 · GM

Megakaryocyte regulation by the gut microbiome

$678,002

Melody Y Zeng · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · HL

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy

$677,986

Lisa A. Cavacini · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI

Broad-spectrum therapeutics against SARS-CoV-2 3CL protease

Porous silicon microparticle-based subunit vaccines for SARS-CoV-2

Developing a dynamic modeling framework for surveillance, prediction, and real-time resource allocation to reduce health disparities during Covid-19 and future pandemics

Administrative Supplement to Real-time Wideband Cardiac MRI for Patients with a Cardiac Implantable Electronic Device

Biophotonics

COVID-19 Sample Collection and Vaccine Studies

Electrophysiological representations of odor in the human brain

Therapeutic Electrical Stimulation Using Wireless, Resorbable Implants to Accelerate Diaphragm Muscle Reinnervation after Phrenic Neuropathy

Administrative Core

Determinants of Early Childhood Immune Responses

Dynamic Interactions of the S-Nitrosoproteome in Type 2 Diabetes/Metabolic Syndrome and Alzheimer's Disease

Early Drivers of Humoral Immunity to SARS-CoV-2 Infections

Systems modeling to address the social and biological drivers of disparities in infection and mortality from emerging infectious diseases

Improving the Collaborative Health of Minority COVID-19 Survivor & Carepartner Dyads Through Interventions Targeting Social and Structural Health Inequities

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

Mitochondrial deubiquitinase USP30 regulates cell metabolism-mediated miRNA biogenesis and microvascular inflammation

Discovery of SARS-CoV-2 antivirals using a replicon assay

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

Long-Term Endothelial Effects of COVID-19 in Obesity

Serological Science for COVID-19 SeroNet

Functional Role of HIF-PHDs in ARDS

Long-Term Endothelial Effects of COVID-19 in Obesity

Emergence, Progression and Impact of SARS-CoV-2 Variants in West Virginia

Megakaryocyte regulation by the gut microbiome

Structure-guided and epitope-based design of potent and broadly neutralizing nanobodies for COVID-19 mucosal immunotherapy